A carregar...
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis
AIM: To evaluate adverse events in cancer patients with pre-existing sarcoidosis receiving immune checkpoint inhibitors (ICIs). PATIENTS & METHODS: We retrospectively reviewed cancer patients with sarcoidosis who underwent treatment with ICI to determine frequency of sarcoidosis flares. RESULTS:...
Na minha lista:
| Publicado no: | Immunotherapy |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983044/ https://ncbi.nlm.nih.gov/pubmed/33641345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0272 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|